Home > Products > IL13 & IL4
> Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (CrossMab)
Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (CrossMab) (CAT#: CROSSAB-173)
Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Idiopathic pulmonary fibrosis therapy.
There are currently no customer reviews or questions for Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (CrossMab) (CROSSAB-173). Click the button below to contact us or submit your feedback about this product.